Skip to main content

06-12-2019 | Linagliptin | ADA 2019 | Article

Expert commentary: An endocrinologist's view of the CAROLINA trial

Conference coverage direct to your inbox
Sanjay Kalra tells us why he is so reassured by the findings of the CAROLINA trial pitting linagliptin against glimepiride (2:38).

More on this topic

Back to the conference hub

Related topics

Image Credits